血清氧脂素谱分析识别极早发痛风年轻男性的独特谱系和潜在生物标志物
该研究对90名20岁以下男性(30例极早发痛风、30例无症状高尿酸血症、30例血尿酸正常)进行血清氧脂素谱分析,分为发现集和验证集。发现集显示痛风与高尿酸血症比较有21种差异氧脂素,痛风与血尿酸正常比较有14种差异氧脂素,14(S)-HDHA为枢纽代谢物。验证集中7种(痛风vs高尿酸血症)和5种(痛风vs血尿酸正常)下调氧脂素得到验证,14(S)-HDHA单独诊断两者的曲线下面积均为1(95%CI,1,1)。结论认为极早发痛风年轻男性具有独特氧脂素谱,差异氧脂素可作为鉴别痛风与高尿酸血症的候选血清生物标志物。
要点
- 极早发痛风年轻男性血清氧脂素谱与无症状高尿酸血症及血尿酸正常者不同。
- 发现集中痛风vs高尿酸血症有21种差异氧脂素,痛风vs血尿酸正常有14种差异氧脂素。
- 验证集中14(S)-HDHA单独鉴别痛风与高尿酸血症或血尿酸正常的AUC均为1(95%CI,1,1)。
核心结论
- 极早发痛风年轻男性具有独特氧脂素谱,尤其是源自花生四烯酸、二十碳五烯酸和二十二碳六烯酸的氧脂素。
- 差异氧脂素可作为候选血清生物标志物用于鉴别痛风与高尿酸血症。
研究设计与样本
- 对90名20岁以下男性(30例极早发痛风、30例无症状高尿酸血症、30例血尿酸正常)进行血清氧脂素谱分析,分为发现集和验证集。
- 采用正交投影偏最小二乘判别分析分析数据集,并进行相关网络和通路富集分析。
- 在验证队列中评估和优化候选氧脂素,构建联合或不联合血清尿酸的诊断模型。
主要发现
- 发现集中痛风vs高尿酸血症比较发现21种差异氧脂素,痛风vs血尿酸正常比较发现14种差异氧脂素。
- 相关网络分析确定14(S)-HDHA在两种比较中均为枢纽代谢物。
- 验证集中痛风vs高尿酸血症组有7种下调氧脂素得到验证,痛风vs血尿酸正常组有5种下调氧脂素得到验证。
- 用上述氧脂素构建诊断模型,14(S)-HDHA单独在两种比较中的曲线下面积均为1(95%CI,1,1)。
关键数值与推荐
- 14(S)-HDHA单独鉴别痛风与高尿酸血症的AUC为1(95%CI,1,1)。
- 14(S)-HDHA单独鉴别痛风与血尿酸正常的AUC为1(95%CI,1,1)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Oxylipins modulate inflammation via complex pathways. The oxylipin profile in gout remains unexplored. In this study, we systemically profiled oxylipins in young men and identified new oxylipin biomarkers for clinical use in differentiating gout from hyperuricaemia. MATERIAL AND METHODS: Oxylipin profiling was performed in 90 men (30 very early onset gout, 30 asymptomatic hyperuricaemia [HU] and 30 normouricaemia [NU], all aged <20 years) divided into discovery and validation sample sets. The dataset was analysed based on orthogonal projection to latent structure-discriminant analysis. Correlation network and pathway enrichment were conducted to reveal potential oxylipin-involved pathways of gout. Candidate oxylipins were further evaluated and optimized in the validation cohort, and differential oxylipin biomarkers combined with or without serum urate were applied to construct diagnostic models. RESULTS: In discovery stage, 21 differential oxylipins in the gout vs HU comparisons and 14 differential oxylipins in the gout vs NU comparisons were discovered. Correlation network analysis was performed and 14(S)-HDHA (14S-hydroxy-4Z,7Z,10Z,12E,16Z,19Z-docosahexaenoic acid) was identified as a hub metabolite in both comparisons. Seven down-regulated oxylipins in the gout vs HU group and five down-regulated oxylipins in the gout vs NU group were validated. Diagnostic models were constructed with the above oxylipins, with 14(S)-HDHA alone having an area under the curve of 1 (95% CI, 1, 1) in both comparisons. CONCLUSIONS: Young men with very early onset gout have distinct oxylipin spectrums, especially those derived from arachidonic acid, eicosapentaenoic acid and docosahexaenoic acid. Differential oxylipins could serve as candidate serum biomarkers in differentiating gout from hyperuricaemia.
引用
- Wang C, Lu J, Sun W, et al. Profiling of serum oxylipins identifies distinct spectrums and potential biomarkers in young people with very early onset gout. Rheumatology (Oxford). 2023. PMID: 36111871. doi:10.1093/rheumatology/keac507
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。